|
PAXIL
Paxil, a selective serotonin reuptake inhibitors has been associated with the ability to induce violence and suicide among children taking the prescibed medication.
FDA Warnings:
- Serotonin reuptake inhibitors increase the risk of suicidal thinking and behavior (suicidality) in children and adolescents with MDD and other psychiatric disorders.
- Anyone considering the use of an antidepressant in a child or adolescent for any clinical use must balance the risk of increased suicidality with the clinical need.
- Patients who are started on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior.
- Families and caregivers should be advised to closely observe the patient and to communicate with the prescriber.
- A statement regarding whether the particular drug is approved for any pediatric indication(s) and, if so, which one(s).
May 2004
Stronger WARNING for SSRIs and other newer anti-depressants regarding the potential for behavioural and emotional changes, including risk of self-harm. For paroxetine, this replaces the previous interim contraindication. Source: Health Canada.
If you feel that you or a family member has been the victim of violent, destructive, suicidal or irrational behavior induced by use of Paxil and may warrant legal actions or mass legal action, please fill out tour contact form today.
|
 |
|
